(Finance) – Talea Groupa company born from the rebranding of Farmaè and leader in the e-retailing of products related to personal health and well-being and in media and digital transformation services for businesses, announces that, in relation to the capital increase approved by the Shareholders’ Meeting of the Shareholders on 14 November 2024 and ongoing as of today, all the option rights held by the majority shareholders were sold to primary investors on the stock market (RIAC Holding 56.81% and MDF Holding 17.15%), ahead of the closing of their trading on the market, expected today.
The sale, explains a note, concerned the totality of the rights due to the two reference shareholders, for a total amount of 5,262,963 rights, divided as follows: n. 200,000 rights transferred by Riccardo Iacometti; n. 3,889,160 rights transferred by Riccardo Iacometti through RIAC Holding; n. 1,173,803 rights transferred by Marco Di Filippo through MDF Holding.
The operation represents a “strategic choice” by the reference shareholders aimed at encouraging the expansion of the shareholding structure and the free float.
The company also reminds you that the option rights must be exercised, under penalty of forfeiture, in the current offer period, which will end on 12 December included. The option rights valid for the subscription of the New Ordinary Shares not exercised by the end of the Offer Period, will be offered, with ISIN code IT0005623449, by the Company on EGM, for at least two open market days in the open stock market sessions that will be communicated to the market pursuant to the applicable legal and regulatory provisions, unless early closure.